Newsroom
Link to: Client news
Client news
The latest news from Optimum clients
Follow a manual added link
Optimum’s EU Life Science Investor Survey 2025
Download the report now for direct insights from leading European investors
Link to: Weekly round-up: Catching up with the news after the busiest week in European biotech comes to a close
Weekly wrap-up
Read Optimum’s round-up for the low-down on client and industry news
Mapping opportunities and challenges in biotech investment
/in InsightsBridging the investment gap between drug discovery and clinical development in oncology
/in InsightsPan European M&A at record levels in 2018
/in InsightsEuropean biotechnology meets crowdfunding
/in InsightsHow is tech transforming developments in healthcare?
/in InsightsRecent developments in UK Crowdfunding
/in InsightsThe Euronext TechShare project.
/in InsightsOptimum Strategic Communications client, Ziylo, acquired by Novo Nordisk in deal that could exceed US$800m
/in InsightsNew tools and technologies to streamline IR
/in InsightsMiFID II and Consensus numbers, what does it mean for IR teams?
/in InsightsLiving In The MIFID World – THURSDAY, 14 JUNE 2018
/in InsightsHighlights from the 9th Annual Healthcare Investor Conference at Bloomberg
/in InsightsCurrent public market environment and equity investor views
/in InsightsBiotech is “hot” and M&A deals are likely to be an ongoing feature of the industry
/in InsightsScaling up a Company to $10bn-$20bn
/in Insights